Drug Type Small molecule drug |
Synonyms VC 005, VC-005, VC005 |
Target |
Mechanism JAK1 inhibitors(Tyrosine-protein kinase JAK1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Atopic | Phase 2 | CN | - | 30 Jun 2023 |
Ankylosing Spondylitis | Phase 2 | CN | - | 21 Apr 2023 |
Rheumatoid Arthritis | Phase 1 | CN | - | 06 Jun 2023 |
Inflammation | Phase 1 | CN | 30 Jan 2022 | |
Inflammatory Bowel Diseases | Phase 1 | CN | - | 02 Nov 2021 |
Eczema | IND Approval | CN | 17 Mar 2023 |